ScienceDirect® Home Skip Main Navigation Links
You have guest access to ScienceDirect. Find out more.
 
Home
Browse
My Settings
Alerts
Help
 Quick Search
 Search tips (Opens new window)
    Clear all fields    
Neuropsychologia
Volume 45, Issue 2, 2007, Pages 357-367
 
Font Size: Decrease Font Size  Increase Font Size
 Abstract - selected
Article
Purchase PDF (436 K)

  E-mail Article   
  Add to my Quick Links   
Bookmark and share in 2collab (opens in new window)
Request permission to reuse this article
  Cited By in Scopus (0)
 
 
 
Related Articles in ScienceDirect
View More Related Articles
 
View Record in Scopus
 
doi:10.1016/j.neuropsychologia.2006.06.014    How to Cite or Link Using DOI (Opens New Window)
Copyright © 2006 Elsevier Ltd All rights reserved.

Dopamine asymmetry interacts with medication to affect cognition in Parkinson's disease

Rachel Tomera, b, c, Corresponding Author Contact Information, E-mail The Corresponding Author, Judith Aharon-Peretzc and Zina Tsitrinbauma, b

aDepartment of Psychology, University of Haifa, Mt. Carmel, Haifa 31905, Israel bBrain and Behavior Center, University of Haifa, Haifa, Israel cCognitive Neurology Unit, Rambam Medical Center, Israel

Received 1 December 2005; 
revised 19 May 2006; 
accepted 2 June 2006. 
Available online 28 July 2006.

Purchase the full-text article



References and further reading may be available for this article. To view references and further reading you must purchase this article.

Abstract

Contradictory evidence exists regarding the nature and degree of impaired cognitive flexibility in PD. Dopaminergic medication may be expected to ameliorate such cognitive deficits, yet both medicated and unmedicated patients have been reported to perform more poorly than control subjects on tasks of cognitive flexibility, suggesting that such deficits may also be affected by other disease-related variables. The present study examined whether asymmetric dopamine deficiency (revealed by unilateral symptom onset) is related to the performance of spontaneous and reactive flexibility in PD, and the possible interaction of dopaminergic medication with such asymmetry. Thirty-five PD patients with mild motor symptoms and unilateral onset of PD (left-onset = 14; right-onset = 21) performed the Alternate Uses (AU) and intradimensional/extradimensional shift (IED) tasks. Interaction between side of onset and medication was observed for the number of errors in the AU task and number of reversal errors in the IED task. Significantly more AU errors were made by medicated patients with left-onset, as compared to all other participants. Conversely, medicated patients with right-onset made the most reversal errors. These results suggest that relatively early in the disease process when dopamine deficit in the less-affected hemisphere is mild, optimal dopaminergic medication (with respect to motor function) may involve over-medication of the less-affected hemisphere. Thus, AU errors may be the consequence of hyperdopaminergic state leading to impaired functioning of the left hemisphere, whereas increased reversal errors in right-onset PD patients receiving dopaminergic medication is related to impaired dopamine function in the right hemisphere.

Keywords: Cognitive flexibility; Fronto-striatal projection; Reversal learning; Ideational fluency

Article Outline

1. Introduction
2. Methods
2.1. Subjects
2.2. Procedure
2.2.1. Side of onset
2.3. Cognitive assessment
3. Results
3.1. Demographic and clinical characteristics
3.2. Onset asymmetry and cognitive flexibility
3.2.1. Spontaneous flexibility
3.2.2. Reactive flexibility
3.3. Cognitive flexibility and clinical symptoms
4. Discussion
4.1. Spontaneous versus reactive flexibility in PD: the effect of asymmetric DA deficiency
4.2. Interaction of asymmetry with medication status
Acknowledgements
References




 
Home
Browse
My Settings
Alerts
Help
Elsevier.com (Opens new window)
About ScienceDirect  |  Contact Us  |  Information for Advertisers  |  Terms & Conditions  |  Privacy Policy
Copyright © 2008 Elsevier B.V. All rights reserved. ScienceDirect® is a registered trademark of Elsevier B.V.